Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis

机译：用于治疗广义焦虑症的致癌物质：META分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Despite multiple drugs available, a large proportion of patients with generalized anxiety disorder (GAD) do not show adequate response and remission. Thus, additional novel pharmacological agents are needed to increase treatment option for GAD. We aimed to investigate efficacy and safety of agomelatine in the treatment of GAD by conducting a meta-analysis.

机译：尽管有多种药物可用，但大部分患有一般性焦虑症（GAD）的患者不表现出足够的反应和缓解。因此，需要额外的新型药理剂来增加GAD的处理选择。我们旨在通过进行META分析来研究Agomelatine治疗GAD的疗效和安全性。

著录项

期刊名称 Clinical Psychopharmacology and Neuroscience
作者
Sheng-Min Wang; Young Sup Woo; Nak-Young Kim; Hae-Ran Na; Hyun Kook Lim; Won-Myong Bahk;
展开▼
作者单位

展开▼
年(卷),期 2020(18),3
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类神经科学;
关键词
Agomelatine; Anxiety disorder; Clinical trial; Treatment; Meta-analysis;

相似文献

外文文献
中文文献
专利

1. Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis [J] . Sheng-Min Wang, Young Sup Woo, Nak-Young Kim, Clinical Psychopharmacology and Neuroscience . 2020,第3期

机译：用于治疗广义焦虑症的致癌物质：META分析
2. Agomelatine for the treatment of generalized anxiety disorder [J] . Buoli Massimiliano, Grassi Silvia, Serati Marta, Expert opinion on pharmacotherapy . 2017,第13a18期

机译：针灸治疗广泛性焦虑症
3. Profile of agomelatine and its potential in the treatment of generalized anxiety disorder [J] . Michelle Nigri Levitan, Marcelo Papelbaum, Antonio Egidio Nardi Neuropsychiatric Disease and Treatment . 2015,第1期

机译：阿戈美拉汀的概况及其在广泛性焦虑症治疗中的潜力
4. Resilience and metacognitions as predictors of outcome in a randomized controlled treatment trial of generalized anxiety disorder [C] . Hjemdal O., Hagen R., Ottesen Kennair Leif E., World Congress on Resilience. . 2014

机译：随机对照治疗试验的预测因子作为综合焦虑症的随机对照治疗试验的预测因素
5. The Efficacy of Neurofeedback in the Treatment of Individuals with Anxiety-Spectrum Disorders: A Meta-Analysis [D] . Russo, G. Michael. 2021

机译：神经融合背面在焦虑症患者治疗中的疗效 - 分析
6. Profile of agomelatine and its potential in the treatment of generalized anxiety disorder [O] . Michelle Nigri Levitan, Marcelo Papelbaum, Antonio Egidio Nardi 2015

机译：阿戈美拉汀的概况及其在广泛性焦虑症治疗中的潜力
7. Long-term efficacy and safety of agomelatine in non-depressed out-patients with generalized anxiety disorder. A 26-week randomised double-blind placebo-controlled parallel group study following an open-label period of 16 weeks with agomelatine (25 mg/day with the possibility for blinded dose-adjustment to 50 mg/day) [O] . Istvan Bitter 2012

机译：广义焦虑症非抑郁患者的长期疗效和治疗症的安全性。一个26周的随机双盲安慰剂控制并行组在含有胍盐碱的开放标签期间（25毫克/天，致盲剂量调节至50毫克/天）

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅